VINC
Vincerx Pharma, Inc. Common Stock
VINC
VINC
Delisted
VINC was delisted on the 22nd of April, 2025.
35 hedge funds and large institutions have $15.7M invested in Vincerx Pharma, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 12 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
35
Holders Change
-1
Holders Change %
-2.78%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
12
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Walleye Capital
New York
|
$176K |
| 2 |
Citadel Advisors
Miami,
Florida
|
$859K |
| 3 |
ECM
ExodusPoint Capital Management
New York
|
$554K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
$5.42K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
$4.88K |
